ClinicalTrials.Veeva

Menu

Effect of Scalp Nerve Block on the Recovery Quality of Parkinson's Patients After Deep Brain Stimulation

N

Naval Military Medical University

Status

Enrolling

Conditions

Parkinson Disease

Treatments

Other: scalp nerve block combined with intercostal nerve block using 0.5% ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT05353764
SNB-QoR

Details and patient eligibility

About

Patients diagnosed with Parkinson's disease (PD) undergoing deep Brain Stimulation (DBS) have a higher risk of perioperative complications and postoperative pain will affect quality of recovery (QoR) resulting in longer hospitalization time and higher hospital costs. Scalp nerve block (SNB) combined with intercostal nerve block (ICNB)can alleviate postoperative pain while effect of them on postoperative recovery quality of patients diagnosed with PD was unclear. Therefore, the investigators conducted a randomized controlled trails to provide a novel method for enhanced recovery and early prevention and treatment of acute pain after DBS surgery.

Enrollment

88 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with PD who receive elective deep brain stimulation (DBS) surgery
  • Aged ≥ 18
  • American Society of Anesthesiologists (ASA) physical status of I-III
  • Able to communicate normally

Exclusion criteria

  • Allergy to local anesthetics
  • Pre-existing infection at block site
  • Severe coagulopathy
  • Pre-existing neuropathic pain condition
  • Previous history of DBS surgery
  • unwilling to provide informed consent or poor compliance

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

88 participants in 2 patient groups

SNB group
Experimental group
Description:
patients in the SNB group will receive general anesthesia combined with scalp nerve block and intercostal nerve block with 0.5% ropivacaine.
Treatment:
Other: scalp nerve block combined with intercostal nerve block using 0.5% ropivacaine
control group
No Intervention group
Description:
patients in control group will receive general anesthesia without nerve block.

Trial contacts and locations

1

Loading...

Central trial contact

Wenbin Lu; Xiya Yu, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems